Lao People's Democratic Republic vs Oman: Protecting minority investors: Ease of shareholder suits index (0-10)
Lao People's Democratic Republic
30
in 2019
Oman
30
in 2019
Lao People's Democratic Republic rank
175th
Oman rank
175th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Lao People's Democratic Republic
- Oman
How they compare
Lao People's Democratic Republic currently reports 30 against 30 in Oman, a difference of 0.
Across all 7 years both countries report, Oman has been ahead every year.
Lao People's Democratic Republic ranks 175th and Oman ranks 175th of 191 countries.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Lao People's Democratic Republic or Oman?
- Lao People's Democratic Republic, at 30 against 30 in Oman as of 2019.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Lao People's Democratic Republic and Oman?
- 0, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Oman?
- 7 years are reported by both, from 2013 to 2019.
- How do Lao People's Democratic Republic and Oman rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Lao People's Democratic Republic ranks 175th and Oman ranks 175th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.